Welcome to The Medical Roundtable

Expert Experience Interpreting Evidenced-Based Medicine.

Our experts provide their decades of clinical practice and trial experience in a conversational based format that create a compelling discussion.

Don't miss our Clinical Implications and QuizBank to help your improve your knowledge and practice.

Heard at the Roundtable

  • "Over the last 2 decades, professional organizations have issued a number of screening guidelines. Initially, the AUA and ACS were very pro-screening. However, over time, they have acknowledged the fact that screening decisions are complicated, involving tradeoffs between benefits and harms, and that we need to help men make informed decisions."

    Richard Hoffman

  • “The data is pretty convincing that adding an aldosterone blocker on top of standard therapy is effective and an important strategy.”
    ~ Bertram Pitt, MD

  • "If you look at the curve of the decrease in mortality from heart disease for the past 50 years in this country, there is a steady downtrend. But when we break up the data … it indicated that women did not benefit until the last decade."
    Ezra A. Amsterdam, MD

  • “It could be tremendous for prevention in children. After being followed, maybe they will come back to have fewer drug problems, smoking issues.”
    ~ James Dalen

  • "The difference in clinical practice is that individuals may not be as stringent at monitoring, and so I think hyperkalemia gets captured potentially a lot sooner in clinical trials as opposed to in clinical practice."
    Orly Vardeny, PharmD